The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer
NCT06215976
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
78
Enrollment
OTHER
Sponsor class
Conditions
Muscle-Invasive Bladder Carcinoma
Interventions
DRUG:
Metformin Hydrochloride 500 MG
Sponsor
Cairo University